NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Perhaps I'm missing something, but I believe that NWBO already has agreements for the commercial manufacturing of the product that are already approved by the regulating authorities. It's not like they have to spend hundreds of millions on production capability. I do think they'll partner to avoid the cost of building distribution and sales teams, but as I see it, they're well prepared for such a partnership.

To me the question should be, if TLD supports the probability of approval, what's a fair market cap. I believe that number starts at about $1 billion and moves up from there, that's roughly 8 times our current market cap prior to any partnership, which could certainly take it much higher.

If I'm right, and no questions exist with manufacturing, the approval process for the vaccine might actually be much faster than the 6 months typically taken by the FDA, but it should still take many months to prepare the BLA after the trial is unblinded. Is approval possible this year, I have to believe it's a possibility, and will continue to be so as long as a BLA is submitted by Summer.

A BP partnership soon after the TLD is revealed may very well establish the leading candidate to buyout the company, but it's by no means a lock. The $20 billion price tag that seems to have been floated may no longer apply if DCVax-Direct has further validation, in fact it could prove to be worth more than DCVax-L even if it's a few years from potential approval if it's shown to work on multiple cancers.

The point is, we need to see more results, if they're as positive as they appear to be, $20 billion could be a bargain for a buyout of the company.

Gary